Filing Flows › iBio (IBIO) › Q4 FY25 › vs Q4 FY24
iBio (IBIO) Q4 FY25 vs Q4 FY24 (year over year)
iBio's revenue rose $25K (+14%) from $175K in Q4 FY24 to $200K in Q4 FY25.
iBio, Q4 FY25: revenue $200K (+14% year over year), net loss $5.2M, operating cash flow −$4.6M. The chart draws each line against Q4 FY24, the increases inside each band.
Every line
| Line | Q4 FY25 | Q4 FY24 | Change | % |
|---|---|---|---|---|
| Revenue | $200K | $175K | $25K | +14% |
| Other income, net | $35K | −$4.4M | $4.4M | — |
| Net loss | $5.2M | $7.8M | −$2.6M | -34% |
| Costs & expenses | $5.4M | $8.0M | −$2.6M | -32% |
| Operating costs | $5.4M | $3.6M | $1.8M | +51% |
| Research & development | $3.2M | $1.1M | $2.1M | +183% |
| General & admin | $2.2M | $2.4M | −$270K | -11% |
| Operating cash sources | $5.2M | $7.8M | −$2.6M | -34% |
| Depreciation & amortization | $126K | $151K | −$25K | -17% |
| Share-based compensation | $270K | $360K | −$90K | -25% |
| Working capital & other | $152K | $2.4M | −$2.3M | -94% |
| Cash used in operations | $4.6M | $4.9M | −$239K | -5% |
| Net loss absorbed | $5.2M | $7.8M | −$2.6M | -34% |
Questions
How much did iBio's revenue grow year over year in Q4 FY25?
iBio's revenue rose $25K (+14%) from $175K in Q4 FY24 to $200K in Q4 FY25.